New treatments for ADHD
- January 21, 2022
- The REACH Institute
- ADHD Medication,
Newer treatments approved by the Food and Drug Administration (FDA) for pediatric patients with attention-deficit/hyperactivity disorder (ADHD) include two medications that address some of the common issues families have with standard stimulant treatments. Another development is use of devices to manage ADHD symptoms.
Categories
- ADHD
- Anti-racism
- Anxiety
- Assessment & screening
- Autism
- Child mental health
- Coding
- Cognitive behavioral therapy
- College transition
- Culturally responsive
- Depression
- Eating disorders
- Foster care
- Grief
- High-risk children & youth
- LGBTQIA
- Medication
- Parents
- Patient communication
- Pediatric primary care
- School refusal
- Sleep disorders
- Suicide
- Trauma
- Show All Categories
Register for courses
“The opportunity to learn information to help me manage psychiatric conditions in my patients in this time where demand clearly outweighs supply of services, is going to be excellent for me as a PCP in my community.”